Medline Anesthesia Trays Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 1100 kits containing Huons Bupivacaine HCL in Dextrose Injection due to quality issues with the included drug.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 23, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Medical Devices) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP distributed kits containing Huons Co. Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. The recall is classified as Class I.
Which Products Are Affected
- ANESTHESIA TRAY, Medline SKU DYNJRA1355A (UDI/DI 10195327179830), lot numbers: 26CBA272, 26ABS307, 25HBE663, 25FBA408, 25CBG043, 24FBT395
- SPINAL ANESTHESIA TRAY, Medline SKU DYNJRA2151 (UDI/DI 10195327365400), lot number: 24FBT396 1100 kits distributed nationwide in the US, US Virgin Islands, Bahamas, Panama, and Barbados. Recall number Z-2231-2026.
What You Should Do
Check affected lot numbers and contact the recalling firm for further instructions.
Why This Matters
This Class I recall involves spinal and anesthesia kits distributed worldwide that contain a drug product with potential quality and efficacy issues.
Source
FDA recall Z-2231-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.